Revista nº 806

Losilla-Rodriguez et al. Chemsex en pacientes homosexuales Actualidad Médica · Número 806 · Enero/Abril 2019 Páginas 24 a 30 · 30 · Los autores no tienen conflicto de intereses La presente investigación no ha recibido ayudas específicas provenientes de agencias del sector público, sector comercial o entidades sin ánimo de lucro. BIBLIOGRAFÍA 1. McCall H, Adams N, Mason D, Willis J. What is chemsex and why does it matter? BMJ 2015, 3; 351 2. Stuart D.  ChemSex and hepatitis C: a guide for healthcare providers. 1st. ed. London; 2014 3. Zaro I, Navazo T, Vázquez J, García A, Ibarguchi L. Aproximación al ChemSex en España 2016. Imagina Más, Apoyo positivo. [Internet] 2016. [Consultado en Mayo 2018]; Disponible en http://www.infochemsex.com 4. Fernández-Dávila, P. “Sesión de sexo, morbo y vicio”: una aproximación holística para entender la aparición del fenómeno ChemSex entre hombres gais, bisexuales y otros hombres que tienen sexo con hombres en España. Revista Multidisciplinar del Sida 2016;4(7):41-65 5. Gilbart VL, Simms I, Jenkins C, Furegato M, Gobin M, Oliver I, et al. Sex, drugs and smart phone applications: findings from semistructured interviews with men who have sex with men diagnosed with Shigella in England and Wales. Sex Transm Infect 2015;91:598-602 . 6. Coll, J, Fumaz, C.R. Drogas recreativas y sexo en hombres que tienen sexo con hombres: chemsex. Riesgos, problemas de salud asociados a su consumo, factores emocionales y estrategias de intervención. Rev Enf Emerg 2016;15:77-84 7. Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, et al. Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study. Lancet HIV 2014 Oct; 1: e22–31 8. Garin N, Zurita B, Velasco C, Feliú A, Gutierrez M, Masip M, et al. Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross- sectional study. BMJ Open. 2017 Jan 18;7: e014105 9. Pérez-Valero I, Blanco-Arévalo JL. '99 preguntas claves sobre ChemSex'. Fundación GeSIDA, 2017(6):31-90. [Consultado en mayo de 2018]. Disponible en https://es.scribd.com/ document/376815560/GESIDA-Chemsex-Book-Portada- Modificada-1 10. Stolbach A, Paziana K, Heverling H, Pham P. A review of the toxicity of HIV medications II: interactions with drugs and complementary and alternative medicine products. J Med Toxicol Sep 2015;11:326–341. 11. Daskalopoulou, M; Rodger, AJ; Phillips, AN; Speakman, A; Lampe, FC. Prevalence of recreational drug use is indiscriminate across antiretroviral regimens of differing drug- drug interactions among MSM. AIDS. 2016;30 :810-812. 12. Caudevilla F. Chem-safe. Energy Control (ABD). [Consultado en Abril de 2018].Disponible en www.chem-safe.org 13. Mason PE, Kerns WP. Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 2002 Jul; 9:730–739 14. Wynn GH, Cozza KL, Zapor MJ, Wortmann GW, Armstrong SC. Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse. Psychosomatics 2005;46 :79-87 15. Bourne A, Reid D, Hickson F, Torres-Rueda S, Steinberg P, Weatherburn P. “Chemsex” and harm reduction need among gay men in South London. Int J Drug Policy 2015; 26:1171- 1176 16. Halkitis PN, Palamar J, Mukherjee P. Analysis of HIVmedication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS Patient Care STDS 2008 ;22(4):323-335. 17. Stuart, D. Sexualised drug use by MSM: background, current status and response. HIV Nurs 2013; 13: 6–10 18. Bracchi M, Stuart D, Castles R, Khoo S, Back D, Boffito M. Increasing use of “party drugs” in people living with HIV on antiretrovirals: a concern for patient safety. AIDS 2015 ;29: 1585-1592. 19. Folch C, Fernandez-Davila P, Ferrer L, Soriano R, Diez M, Casabona J. Conductas sexuales de alto riesgo en hombres que tienen sexo con hombres según tipo de pareja sexual. Enferm Infecc Microbiol Clin 2014 ; 32: 341-349. 20. Aaron S, McMahon JM, Milano D, Torres L, Clatts M, Tortu S, et al. Intranasal transmission of hepatitis C virus: virological and clinical evidence. Clin Infect Dis 2008;47:931-934. 21. Pascual F, Guardia J, Pereiro C, Bodes J. Alcoholismo: Guías clínicas socidrogalcoholbasadas en la evidencia científica. Barcelona: SANED; 2013 [Consultado en Mayo de 2018]. Disponible en http://www.socidrogalcohol.org/manuales-y- guias-clinicas-de-socidrogalcohol.html 22. Pufall, E, Kall, M, Shahmanesh, M, Nardone, A, Gilson, R, Delpech, V, et al. Sexualized drug use (‘chemsex’) and high‐ risk sexual behaviours in HIV‐positive men who have sex with men. HIV Med 2018 ; 19: 261-270. 23. Bourne A, Reid D, Hickson F, Torres-Rueda S, Weatherburn P. The Chemsex study: drug use in sexual settings among gay & bisexual men in Lambeth, Southwark & Lewisham. London: Sigma Research, London School of Hygiene & Tropical Medicine; 2014. [Consultado en Mayo 2016] Disponible en: www.sigmaresearch.org.uk/chemsex 24. Hegazi A, Lee MJ, Whittaker W, Green S, Simms R, Cutts R, et al. Chemsex and the city: sexualised substance use in gay, bisexual, and other men who have sex with men attending sexual health clinics. Internal J STD AIDS 2017;28: 362-366. 25. Glynn RW, Byrne N, O’Dea S, Shanley A, Codd M, Keenan E, et al. Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Int J Drug Policy 2018; 52:9-15 26. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex 2001; 41:17–35 27. Pakianathan MR, Lee MJ, Kelly B, Hegazi A. How to assess gay, bisexual and other men who have sex with men for chemsex. Sex Transm Infect 2016 Dec; 92: 568–570.